ORCL vs XOM: Which Is the Better Buy?

Side-by-side comparison of Oracle Corporation and Exxon Mobil Corporation โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-05-01.
Oracle Corporation ยท Technology
$175.08
+45.0% upside to fair value
Grade C High Quality
VS
Exxon Mobil Corporation ยท Energy
$154.46
-40.5% upside to fair value
Grade C
QuantHub Verdict
ORCL has more upside to fair value (+45.0%). XOM trades at a lower forward P/E (23.2x). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric ORCL XOM
Current Price $175.08 $154.46
Fair Value Estimate $253.87 $91.87
Upside to Fair Value +45.0% -40.5%
Market Cap $503.5B $642.0B
Forward P/E 30.8x 23.2x
EV / EBITDA 21.4x 10.3x
Price / Sales 7.9x 2.0x
Price / FCF -20.4x 27.2x
Revenue Growth YoY +21.7% -1.3%
Gross Margin 66.4% 21.7%
Operating Margin 30.8% 10.5%
Return on Equity 57.4% 11.0%
Dividend Yield 0% 0%
FCF Yield โ€” 3.68%
Analyst Consensus Strong Buy Buy
Investment Thesis
ORCL โ€” Oracle Corporation
Oracle Corporation is a leading enterprise software and cloud infrastructure provider with a strong legacy in database technology and a growing cloud business. The company benefits from a durable competitive moat supported by high insider ownership, experienced leadership, and a history of strategic acquisitions. Oracle's recent financials show robust revenue growth of 21.7% and earnings growth oโ€ฆ
XOM โ€” Exxon Mobil Corporation
Exxon Mobil Corporation operates as a global integrated oil and gas company with significant operations in upstream, energy products, chemical products, and specialty products segments. The company benefits from a highly experienced management team with decades of internal tenure, led by CEO Darren Woods. Despite strong cash flow generation and operational scale, Exxon is currently overvalued, trโ€ฆ
Accumulation Zones
Metric ORCL XOM
Zone Low $190.40 $68.90
Zone High $215.79 $78.09
In Buy Zone? Yes No
โ† ORCL Research    XOM Research โ†’    All Research